Infection and Chemotherapy

Scope & Guideline

Bridging Science and Clinical Practice in Infectious Diseases

Introduction

Explore the comprehensive scope of Infection and Chemotherapy through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Infection and Chemotherapy in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2093-2340
PublisherKOREAN SOC ANTIMICROBIAL THERAPY
Support Open AccessYes
CountrySouth Korea
TypeJournal
Convergefrom 2011 to 2024
AbbreviationINFECT CHEMOTHER / INFECT. CHEMOTHER.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address806, SEOCHO TOWN TRAPALACE, 23 SEOCHO-DAERO 74-GIL, SEOCHO-GU, SEOUL 06621, SOUTH KOREA

Aims and Scopes

The journal 'Infection and Chemotherapy' primarily focuses on advancing the understanding and treatment of infectious diseases through rigorous research and clinical studies. It aims to provide a platform for the dissemination of knowledge related to infection control, antimicrobial therapy, and emerging infectious threats.
  1. Antimicrobial Resistance and Stewardship:
    A significant focus on the challenges of antimicrobial resistance, including studies on resistance patterns, efficacy of treatment protocols, and strategies for antimicrobial stewardship in healthcare settings.
  2. Infectious Disease Epidemiology:
    Research on the epidemiology of infectious diseases, including outbreak investigations, prevalence studies, and the impact of public health interventions.
  3. Clinical Management of Infectious Diseases:
    Emphasis on clinical studies that evaluate treatment efficacy, safety, and guidelines for managing various infectious diseases, particularly in specific patient populations such as those with HIV or other comorbidities.
  4. Innovative Therapies and Vaccination:
    Exploration of new therapeutic approaches, including phage therapy, monoclonal antibodies, and vaccination strategies against infectious diseases, particularly in response to emerging pathogens.
  5. Global Health and Infectious Diseases:
    A commitment to addressing global health issues related to infectious diseases, including studies from diverse geographical contexts and implications for public health policy.
The journal has notably adapted to emerging health challenges, particularly those posed by the COVID-19 pandemic. Recent publications reflect a shift towards innovative treatments and the management of infectious diseases in a rapidly changing global landscape.
  1. COVID-19 Research and Management:
    A significant increase in research focused on COVID-19, including studies on treatment efficacy, vaccination, and public health responses to the pandemic.
  2. Phage Therapy and Alternative Treatments:
    Emerging interest in phage therapy as an alternative to traditional antibiotics, reflecting a growing recognition of the need for novel approaches to combat antibiotic resistance.
  3. HIV/AIDS Management Innovations:
    Growing emphasis on innovative strategies for managing HIV/AIDS, including long-acting injectable therapies and psychosocial interventions.
  4. Impact of Climate Change on Infectious Diseases:
    An emerging trend in research addressing how climate change affects the epidemiology of infectious diseases, highlighting the need for adaptive public health responses.
  5. Mental Health and Infectious Disease Management:
    Increasing focus on the psychological impact of infectious diseases, particularly in the context of outbreaks and chronic conditions, recognizing the importance of mental health in overall patient care.

Declining or Waning

While 'Infection and Chemotherapy' has consistently published on various topics, certain areas of research are becoming less prominent in recent issues. This may reflect shifts in public health priorities or advances in treatment methods.
  1. Non-communicable Disease Interactions:
    Research examining the interplay between infectious diseases and non-communicable diseases has seen a decline, possibly due to the increased focus on infectious disease management in light of the COVID-19 pandemic.
  2. Traditional Infectious Disease Models:
    The reliance on classical models of infectious disease spread and treatment is less frequent, as newer methodologies and technologies are being adopted.
  3. Historical Perspectives on Infectious Diseases:
    Papers focusing on historical accounts of infectious diseases and their management are appearing less frequently, indicating a shift towards contemporary issues and future-oriented research.

Similar Journals

LANCET INFECTIOUS DISEASES

Connecting Researchers to Combat Global Health Threats
Publisher: ELSEVIER SCI LTDISSN: 1473-3099Frequency: 12 issues/year

LANCET INFECTIOUS DISEASES is a premier journal published by Elsevier Science Ltd, dedicated to disseminating high-quality research and comprehensive reviews in the field of infectious diseases. Since its inception in 2001, the journal has become a pivotal resource in the medical community, recognized for its rigorous peer-review process and impactful contributions to public health. With an impressive Scopus rank of #2 out of 344 in the category of Medicine - Infectious Diseases, it consistently ranks in the 99th percentile, highlighting its importance and influence in shaping clinical and epidemiological research. The journal's commitment to advancing knowledge in infectious diseases is underscored by its Q1 quartile designation in 2023, affirming its status as a leading academic outlet. Although not an open-access journal, LANCET INFECTIOUS DISEASES provides essential insights for researchers, healthcare professionals, and students, bridging the gap between cutting-edge research and practical application in an increasingly interconnected world.

Infectious Microbes & Diseases

Unraveling the complexities of microbes and their impact.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: Frequency: 4 issues/year

Infectious Microbes & Diseases, published by Lippincott Williams & Wilkins, is a premier journal dedicated to the exploration and understanding of infectious diseases, microbiology, and epidemiology. With its focused scope and robust peer-review process, the journal aims to disseminate high-quality research that contributes to advancements in the field, making it an essential resource for researchers, healthcare professionals, and students alike. Established in 2019, it has quickly gained recognition, achieving a Q3 rating in categories such as Epidemiology, Infectious Diseases, and Medical Microbiology in 2023, and ranking in the top half of its field within Scopus metrics. Although currently offered as a subscription-based journal, Infectious Microbes & Diseases significantly enriches its disciplines by inviting innovative research and critical review articles, thus playing a vital role in combating the global challenges posed by infectious diseases.

Southern African Journal of Infectious Diseases

Advancing research for a healthier Southern Africa.
Publisher: AOSISISSN: 2312-0053Frequency: 4 issues/year

Southern African Journal of Infectious Diseases is a pivotal platform for the dissemination and advancement of research in the field of infectious diseases, with a particular focus on issues significant to the Southern African region. Published by AOSIS, this Open Access journal has been committed to providing accessible scholarly content since 2016, enabling researchers and practitioners to stay updated with the latest developments in infectious disease epidemiology, prevention, and management. With the ISSN 2312-0053 and E-ISSN 2313-1810, the journal invites submissions that explore diverse topics, including but not limited to clinical studies, public health policies, and innovative treatment methodologies. The Southern African Journal of Infectious Diseases is an essential resource for academics, professionals, and students dedicated to combating infectious diseases and improving health outcomes in the region, fostering a collaborative approach to research and knowledge sharing.

Journal of Hospital Infection

Exploring Innovations in Infectious Diseases and Microbiology
Publisher: W B SAUNDERS CO LTDISSN: 0195-6701Frequency: 12 issues/year

Journal of Hospital Infection, published by W B SAUNDERS CO LTD, stands as a pivotal resource in the infectious diseases, medicine, and microbiology sectors. With an impressive impact factor positioning it in the Q1 quartile across its relevant categories, this journal not only ranks highly—#32 out of 344 in Infectious Diseases and #17 out of 140 in Medical Microbiology—but also exemplifies a commitment to advancing knowledge and practice in hospital infection control. Since its inception in 1980, the journal has become a vital platform for disseminating research that informs clinical practices, promotes safety in health care environments, and enhances medical education. While access is non-open, the journal's extensive scope and rigorously peer-reviewed contributions ensure its relevance and significance to researchers, professionals, and students aiming to stay at the forefront of this dynamic field. The journal’s headquarters in London underscores its international relevance, making it an essential reference for anyone involved in combating hospital-acquired infections.

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA

Connecting research and clinical insights in infectious disease management.
Publisher: EDICIONES DOYMA S AISSN: 0213-005XFrequency: 10 issues/year

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA is a prominent journal dedicated to the fields of infectious diseases and clinical microbiology, published by EDICIONES DOYMA S A in Spain. With an ISSN of 0213-005X and an e-ISSN of 1578-1852, the journal has been a cornerstone of research and scholarly communication since its inception in 1989. As of 2023, it holds a Q3 category ranking in Infectious Diseases, highlighting its significance in the field, alongside a Q4 ranking in the related area of Microbiology. Although the journal is not open access, it remains an essential resource for professionals, researchers, and students aiming to stay informed on advancements and studies that impact clinical practices in infectious diseases. With Scopus ranks indicating a percentile ranking in the 20th to 34th range across various sub-disciplines, ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA continually contributes to the dialogue and development of science, fostering a deeper understanding of complex microbial interactions and disease mechanisms.

Infectious Diseases and Therapy

Exploring the frontiers of infectious disease management.
Publisher: SPRINGER LONDON LTDISSN: 2193-8229Frequency: 4 issues/year

Infectious Diseases and Therapy is a premier scholarly journal published by Springer London Ltd, dedicated to advancing the understanding of infectious diseases through rigorous research and evidence-based therapy. With an esteemed Q1 ranking in both the Infectious Diseases and Microbiology (medical) categories, this journal is a vital resource for researchers, healthcare professionals, and students aiming to stay at the forefront of developments within the field. Launched in 2012, it has embraced an Open Access model, ensuring that groundbreaking studies and critical reviews are accessible to a global audience. Operating from its office in London, the journal encourages the dissemination of innovative therapies and diagnostic methods, fostering collaboration and knowledge sharing among the scientific community. In a landscape where infectious diseases pose significant health challenges, Infectious Diseases and Therapy stands as an essential platform for impactful research that can lead to improved healthcare outcomes worldwide.

Current Infectious Disease Reports

Pioneering Insights for a Healthier Tomorrow
Publisher: SPRINGERISSN: 1523-3847Frequency: 12 issues/year

Current Infectious Disease Reports, published by SPRINGER, is a leading journal dedicated to advancing knowledge in the field of infectious diseases. With an ISSN of 1523-3847 and an E-ISSN of 1534-3146, this peer-reviewed journal has established itself as a vital resource for researchers and healthcare professionals since its inception in 1999. The journal's impact in the academic community is underscored by its Q1 ranking in Infectious Diseases for 2023, placing it in the top quartile of influential journals in the field. Furthermore, it holds a respectable position at rank #95 out of 344 in the Scopus database, reflecting its substantial contribution to medicine and public health. While currently not an open access journal, it offers a wealth of articles covering the latest research, case studies, and reviews, making it an indispensable tool for those aiming to stay at the forefront of infectious disease science. As we navigate an era marked by emerging and re-emerging infectious threats, Current Infectious Disease Reports remains committed to providing high-quality, relevant research that supports evidence-based practice and informs future studies globally.

Indian Journal of Medical Microbiology

Bridging Science and Clinical Practice in Microbiology
Publisher: ELSEVIERISSN: 0255-0857Frequency: 4 issues/year

Indian Journal of Medical Microbiology, published by Elsevier, is a pivotal peer-reviewed journal dedicated to the field of medical microbiology, providing a vital platform for research and scholarship since its inception in 1986. With an Open Access model established in 2001, it ensures the dissemination of scientific knowledge to a global audience, enhancing accessibility for researchers, professionals, and students alike. The journal's scope spans critical areas including immunology, infectious diseases, and microbiology, with an impressive trajectory marked by converged years of publication allowing for a comprehensive exploration of evolving scientific trends. As of 2023, the journal holds a Q3 ranking in Infectious Diseases and Microbiology (medical) and a Q4 ranking in Immunology and Microbiology categories, reflecting its significant yet growing impact in the field. Researchers seeking to contribute to or stay updated on the latest advancements in medical microbiology will find the Indian Journal of Medical Microbiology a valuable resource, as it consistently bridges the gap between emerging science and clinical application.

Infectious Diseases

Connecting Scholars in the Battle Against Infectious Diseases
Publisher: TAYLOR & FRANCIS LTDISSN: 2374-4235Frequency: 12 issues/year

Infectious Diseases, published by TAYLOR & FRANCIS LTD, is a leading academic journal dedicated to advancing research in the field of infectious diseases and microbiology. With an impressive impact factor and categorized in Q1 in multiple areas including Immunology and Microbiology, this journal serves as a critical platform for researchers, practitioners, and students to disseminate their findings and stay abreast of current advancements. The journal is recognized for its rigorous peer-review process and aims to foster innovation and collaboration across disciplines from 2015 to 2024. It boasts a robust Scopus ranking, positioning it favorably among the top-tier of journals in the relevant fields, making it an essential resource for anyone involved in infectious disease research. Access options are available, ensuring that the latest research is accessible to a global audience, thus emphasizing the journal's commitment to promoting knowledge and understanding in the ever-evolving landscape of infectious diseases.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Empowering Healthcare Through Rigorous Epidemiological Insights
Publisher: CAMBRIDGE UNIV PRESSISSN: 0899-823XFrequency: 12 issues/year

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, published by Cambridge University Press, is a leading academic journal specializing in the critical fields of epidemiology, infectious diseases, and medical microbiology. With a history of publication dating back to 1988 and an expected continuation through 2024, the journal has established itself as a pivotal resource for researchers, healthcare professionals, and students alike. The journal's impact is reflected in its impressive rankings, positioning it in the second quartile for Epidemiology and the first quartile for both Infectious Diseases and Medical Microbiology as of 2023. This esteemed journal is dedicated to the dissemination of high-quality research that informs best practices in infection control and enhances patient safety across healthcare settings. Although access to its content is not open, the rigorous peer-review process ensures that all published articles contribute significantly to the body of knowledge in these vital areas. With a commitment to bridging the gap between research and practice, INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY remains an essential publication for those committed to the advancement of public health and the science of infection prevention.